Furthermore, the PTEN/PI3K/AKT pathway promotes maintenance of stemness in liver, lung, and breast cancers, as well as in chronic myeloid leukemia 30-33. The gene discussed is AKT1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.